INS and diabetes mellitus: These agents have been investigated widely as an adjunct to therapy in diabetes as they offer an obvious alternative to insulin, but their metabolic effect could also be extended to the heart as they can enable the heart to switch to the more energy-efficient glucose-dependent pathway [10].